Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.725 USD | -1.75% | +1.97% | -45.91% |
Business Summary
Number of employees: 58
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Molecular Testing Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -98.69% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -98.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 19-04-30 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 23-04-30 |
Paul W. Shabram
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-24 |
Sharat Singh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Rhode
PRN | Corporate Officer/Principal | - | - |
Allison Luo
PRN | Corporate Officer/Principal | 50 | 17-05-31 |
Robyn Hatton
HRO | Human Resources Officer | - | 13-07-31 |
Clarke Neumann
LAW | General Counsel | 60 | 14-08-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 14-05-31 | |
Jeffrey Alter
CHM | Chairman | 61 | 18-12-31 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 21-11-07 |
Lynne Powell
BRD | Director/Board Member | 57 | 19-01-31 |
Brian Kotzin
BRD | Director/Board Member | 74 | 19-05-31 |
Jill Howe
BRD | Director/Board Member | 48 | 21-11-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 36,621,198 | 35,588,352 ( 97.18 %) | 737,355 ( 2.013 %) | 97.18 % |
Company contact information
Biora Therapeutics, Inc.
4330 La Jolla Village Drive Suite 300
92122, San Diego
+833 727 2841
http://www.progenity.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-45.91% | 26.48M | |
+7.76% | 111B | |
+11.24% | 106B | |
-12.35% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.61% | 16.81B | |
+38.91% | 12.54B | |
-24.32% | 8.09B |
- Stock Market
- Equities
- BIOR Stock
- Company Biora Therapeutics, Inc.